Results Highlights for Interim Results ended 30 June 2025Revenue reached RMB831.9 millionGross profit amounted to RMB339.4 millionGross profit margin was 40.8%, an increase of 6.3 percentage pointNet profit amounted to RMB148.6 million, increased by 3.1% YoYAdjusted non-IFRS net profit reached RMB183.5 million, increased by 9.1% YoYSHANGHAI, Aug. 28, 2025 /PRNewswire/ -- On August 28, 2025, Viva Biotech Holdings Group ("Viva Biotech", "the Group" or "the Company", stock code: 1873.HK) announced that the Gro ...